Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

10.80 -4.45 (-29.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,672,471
Open 10.32
Bid (Size) 10.77 (1,600)
Ask (Size) 10.85 (100)
Prev. Close 15.25
Today's Range 9.580 - 10.83
52wk Range 11.02 - 19.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance ↗
On Aug. 13, 2026, the digital forensics firm reported delays in large transactions and heightened demand for cloud and AI procurement, prompting a leadership change. 
Via The Motley Fool
Topics Artificial Intelligence Earnings Initial Public Offering
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill

Performance

YTD
-39.5%
-39.5%
1 Month
-33.0%
-33.0%
3 Month
-10.7%
-10.7%
6 Month
-24.3%
-24.3%
1 Year
-22.4%
-22.4%

More News

Read More
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Cellebrite DI Ltd (NASDAQ:CLBT) Q1 Results Miss Revenue Target but Beat EPS ↗
Via Chartmill
Cellebrite DI Ltd (NASDAQ:CLBT) Reports Record Q4 2025 Results Amid Mixed Market Reaction ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Cellebrite DI Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Full Transcript: Cellebrite DI Q2 2026 Earnings Call ↗
Via Benzinga
Topics Earnings
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Stride Stock Is Down 40% This Past Year. Here's Why One Investor Added $58 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Choice Hotels Stock Is Down 15%, but One Investor Bought $101 Million Last Quarter ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
What to Know About This Fund's $59 Million Astronics Bet Amid a 170% One-Year Stock Surge ↗
Via The Motley Fool
Topics Energy Regulatory Compliance Supply Chain
News headline image
This Chip Stock Soared 325%. Why One Investor Still Sold $89 Million Worth ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Cellebrite (CLBT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cellebrite DI Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Cellebrite: Is This Stock Worth the Investment? ↗
Via The Motley Fool
News headline image
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter ↗
Via The Motley Fool
News headline image
Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cellebrite (CLBT) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Norwood Investment Partners Opens New $4.3 Million Cellebrite Position ↗
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
10 AI Stocks Worth Buying Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is Cellebrite DI Ltd. - Ordinary Shares publicly traded?
Yes, Cellebrite DI Ltd. - Ordinary Shares is publicly traded.
What exchange does Cellebrite DI Ltd. - Ordinary Shares trade on?
Cellebrite DI Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cellebrite DI Ltd. - Ordinary Shares?
The ticker symbol for Cellebrite DI Ltd. - Ordinary Shares is CLBT on the Nasdaq Stock Market
What is the current price of Cellebrite DI Ltd. - Ordinary Shares?
The current price of Cellebrite DI Ltd. - Ordinary Shares is 10.80
When was Cellebrite DI Ltd. - Ordinary Shares last traded?
The last trade of Cellebrite DI Ltd. - Ordinary Shares was at 08/13/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.